Method of producing four-component live culture vaccine against measles, varicella, mumps, and rubella
RU2693440C1
STRAIN "vFIRAVAX" FOR PRODUCING AN ATTENUATED ALIVE CULTURE VACCINE FOR PREVENTING VARICELLA
RU2715899C1
Method for quantitative determination in vaccine preparation of antigen adsorbed on aluminium hydroxide particles
RU2689903C1
Freshly isolated strain of bordetella pertussis bacteria - producer of a complex of protective antigens for production of cell-free pertussis vaccine
RU2686337C1
Method of determining antimicrobial activity of whole serum and fraction of its antimicrobial peptides
RU2711907C2
Recombinant protein containing antigen-significant fragments of hepatitis e virus proteins, used in test systems for hepatitis e serodiagnosis (embodiments)
RU2670091C1
Method for delivering nanoparticles intended for the transport of drugs to the brain of mammals through the blood-brain barrier
RU2670514C1
Method for obtaining attenuated strains of influenza a virus - candidates for live influenza vaccines
RU2677790C1
RECOMBINANT PLASMID pPA-OPRF-ATOX-OPRI DNA, WHICH ENCODES SYNTHESIS OF HYBRID RECOMBINANT PROTEIN, INCLUDING AMINO ACID SEQUENCES OF PROTEIN F AND I OF EXTERNAL MEMBRANE AND ATOXIC VARIANT OF A PSEUDOMONAS AERUGINOSA EXOTOXIN, ESCHERICHIA COLI PA-OPRF-ATOX-OPRI STRAIN - PRODUCER OF HYBRID RECOMBINANT PROTEIN AND METHOD OF OBTAINING SPECIFIED PROTEIN
RU2660365C1
Method for obtaining specific antigenic preparations from clinically significant yeast fungi
